Back to User profile » Dr Mulugeta Russom
Papers published by Dr Mulugeta Russom:
Survival and Its Determinants of HIV/AIDS Patients Receiving Antiretroviral Therapy in Two National Referral Hospitals in Eritrea: A Retrospective Cohort Study
Kibreab F, Russom M, Berhane A, Araia MM, Bamidele MA, Cleenewerck de Kiev L
Infection and Drug Resistance 2025, 18:4165-4178
Published Date: 18 August 2025
Household Pharmaceutical Disposal Practices, Community Understanding, and Readiness for Medicines Take-Back in Asmara, Eritrea: A Cross-Sectional Analysis
Habte HY, Bahta M, Russom N, Kibreab F, Andemariam A, Tewelde T, Russom M
Risk Management and Healthcare Policy 2024, 17:2777-2788
Published Date: 11 November 2024
Toxic Epidermal Necrolysis Associated with Misoprostol: A Case Report
Frezgi O, Russom M
International Medical Case Reports Journal 2023, 16:385-390
Published Date: 24 June 2023
Awareness, Perception, and Utilization of Skin Lightening Agents Among Females of Asmara, Eritrea: A Cross-Sectional Study
Tesfamariam S, Bahta M, Weldemariam DG, Tesfamariam EH, Yemane H, Bahta I, Russom M
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1191-1202
Published Date: 8 May 2023
Knowledge and Perceptions of Nurse Practitioners on Adverse Events Following Immunization and Barriers to Reporting in the Central Region, Eritrea: A Cross-Sectional Study
Abdu N, Mosazghi A, Yehdego T, Tesfamariam EH, Russom M
Drug, Healthcare and Patient Safety 2022, 14:125-134
Published Date: 25 July 2022
Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
Russom M, Jeannetot DYB, Tesfamariam S, Stricker BH, Verhamme K
Risk Management and Healthcare Policy 2022, 15:1407-1419
Published Date: 23 July 2022
Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment
Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, Gil JP
Pharmacogenomics and Personalized Medicine 2020, 13:571-575
Published Date: 12 November 2020
Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study
Bahta M, Berhe T, Russom M, Tesfamariam EH, Ogbaghebriel A
Integrated Pharmacy Research and Practice 2020, 9:205-217
Published Date: 14 October 2020
Amoxicillin and Risk of Hearing Loss: Analysis of Reported Cases Submitted to the WHO Global Database
Russom M, Afendi A, Ghebrenegus AS
Drug, Healthcare and Patient Safety 2020, 12:145-149
Published Date: 21 August 2020